Neumora Therapeutics is trading 11.04% higher at $0.52 before the October 8, 2026 open, with no verified company-specific catalyst identified. - Shares closed at $0.47 on October 7. - The latest company releases surfaced in the search were from August. - Broader markets are weak, and the available evidence does not establish a clear reason for the gain.